PRICE T ROWE ASSOCIATES INC /MD/ - AIM IMMUNOTECH INC ownership

AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 43 filers reported holding AIM IMMUNOTECH INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of AIM IMMUNOTECH INC
ValueSharesWeighting
Q1 2023$9
-75.0%
20,300
-82.5%
0.00%
Q4 2022$36
-99.9%
115,7000.0%0.00%
Q3 2022$68,000
-25.3%
115,700
-0.9%
0.00%
Q2 2022$91,000
-26.6%
116,8000.0%0.00%
Q1 2022$124,000
+15.9%
116,8000.0%0.00%
Q4 2021$107,000
-54.7%
116,8000.0%0.00%
Q3 2021$236,000
-6.0%
116,8000.0%0.00%
Q2 2021$251,000
-5.3%
116,8000.0%0.00%
Q1 2021$265,000
+26.8%
116,8000.0%0.00%
Q4 2020$209,000
-16.7%
116,8000.0%0.00%
Q3 2020$251,000116,8000.00%
Other shareholders
AIM IMMUNOTECH INC shareholders Q4 2021
NameSharesValueWeighting ↓
XTX Topco Ltd 29,269$63,0000.02%
SeaCrest Wealth Management, LLC 43,563$94,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 246,000$529,0000.01%
Lehman & Derafelo Financial Resources LLC 11,100$24,0000.01%
WINTON GROUP Ltd 54,894$118,0000.01%
Traynor Capital Management, Inc. 11,777$24,0000.00%
Community Bank, N.A. 13,226$28,0000.00%
SNS Financial Group, LLC 10,000$22,0000.00%
Verition Fund Management LLC 108,000$232,0000.00%
Schonfeld Strategic Advisors LLC 23,100$49,0000.00%
View complete list of AIM IMMUNOTECH INC shareholders